SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-22-016539
Filing Date
2022-03-04
Accepted
2022-03-04 21:09:44
Documents
1
Period of Report
2022-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4350
  Complete submission text file 0001209191-22-016539.txt   5760
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O KURA ONCOLOGY, INC. 3033 SCIENCE PARK RD, SUITE 220 SAN DIEGO CA 92121
Business Address
BASTA JAMES (Reporting) CIK: 0001792726 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37766 | Film No.: 22716034